Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kislay Roy, Rupinder Kaur Kanwar & Jagat Rakesh Kanwar. (2015) Molecular targets in arthritis and recent trends in nanotherapy. International Journal of Nanomedicine 10, pages 5407-5420.
Read now
Read now
Eva Skaleric, Milan Petelin, Boris Gaspirc & Uros Skaleric. (2012) Periodontal inflammatory burden correlates with C-reactive protein serum level. Acta Odontologica Scandinavica 70:6, pages 520-528.
Read now
Read now
Per Qvist, Claus Christiansen, Morten A. Karsdal, Suzi Høgh Madsen, Bodil Cecilie Sondergaard & Anne-Christine Bay-Jensen. (2010) Application of biochemical markers in development of drugs for treatment of osteoarthritis. Biomarkers 15:1, pages 1-19.
Read now
Read now
Y Valle, IY Ledezma-Lozano, N Torres-Carrillo, JR Padilla-Gutiérrez, RE Navarro-Hernández, M Vázquez-Del Mercado, CA Palafox-Sánchez, J Armendáriz-Borunda & JF Muñoz-Valle. (2009) Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis. Scandinavian Journal of Rheumatology 38:5, pages 332-335.
Read now
Read now
Articles from other publishers (34)
Samara V. Silver & Petra Popovics. (2023) The Multifaceted Role of Osteopontin in Prostate Pathologies. Biomedicines 11:11, pages 2895.
Crossref
Crossref
Beatriz Teresita Martín-Márquez, Flavio Sandoval-García, Fernanda Isadora Corona-Meraz, Erika Aurora Martínez-García, Pedro Ernesto Sánchez-Hernández, Mario Salazar-Páramo, Ana Lilia Fletes-Rayas, Daniel González-Inostroz & Monica Vazquez-Del Mercado. (2023) Osteopontin: A Bone-Derived Protein Involved in Rheumatoid Arthritis and Osteoarthritis Immunopathology. Biomolecules 13:3, pages 502.
Crossref
Crossref
Boglárka Soós, Ágnes Szentpétery, Hennie G. Raterman, Willem F. Lems, Harjit P. Bhattoa & Zoltán Szekanecz. (2022) Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nature Reviews Rheumatology 18:5, pages 249-257.
Crossref
Crossref
Richard F. Loeser, Liubov Arbeeva, Kathryn Kelley, Anthony A. Fodor, Shan Sun, Veronica Ulici, Lara Longobardi, Yang Cui, Delisha A. Stewart, Susan J. Sumner, M. Andrea Azcarate‐Peril, R. Balfour Sartor, Ian M. Carroll, Jordan B. Renner, Joanne M. Jordan & Amanda E. Nelson. (2022)
Association of Increased Serum Lipopolysaccharide, But Not Microbial Dysbiosis, With
Obesity‐Related
Osteoarthritis
. Arthritis & Rheumatology 74:2, pages 227-236.
Crossref
Crossref
Katie Trinh, Sohel M. Julovi & Natasha M. Rogers. (2022) The Role of Matrix Proteins in Cardiac Pathology. International Journal of Molecular Sciences 23:3, pages 1338.
Crossref
Crossref
John C.W. Hildyard, Dominique O. Riddell, Rachel C.M. Harron, Faye Rawson, Emma M.A. Foster, Claire Massey, Frances Taylor-Brown, Dominic J. Wells & Richard J. Piercy. (2022) The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy. Wellcome Open Research 7, pages 238.
Crossref
Crossref
Anamika Dwivedi, Abhimanyu Kumar Jha & Varsha Gupta. (2020) Effects of MTHFR genetic polymorphism on inflammatory protein osteopontin in RA patients: A gender based study in North Indian population. Gene Reports 20, pages 100737.
Crossref
Crossref
Konstantinos Maniatis, Gerasimos Siasos, Evangelos Oikonomou, Manolis Vavuranakis, Marina Zaromytidou, Konstantinos Mourouzis, Thodoros Paraskevopoulos, Georgios Charalambous, Athanasios G. Papavassiliou & Dimitris Tousoulis. (2020) Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients. Current Vascular Pharmacology 18:5, pages 523-530.
Crossref
Crossref
Elham Yaghubi, Maryam Daneshpazhooh, Mahmoud DJalali, Hamed Mohammadi, Farnaz Sepandar, Zahra Fakhri, Ehsan Ghaedi, Seyed Ali Keshavarz, Kamran Balighi, Hamidreza Mahmoudi, Mahnaz Zarei & Mohammad Hassan Javanbakht. (2019)
Effects of
l
‐carnitine supplementation on cardiovascular and bone turnover markers in patients with pemphigus vulgaris under corticosteroids treatment: A randomized, double‐blind, controlled trial
. Dermatologic Therapy 32:5.
Crossref
Crossref
Jeneen Panezai, Ambereen Ghaffar, Mohammad Altamash, Per-Erik Engström & Anders Larsson. (2018) Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis. PLOS ONE 13:6, pages e0197235.
Crossref
Crossref
Peng Wang, Si Li, Li-Na Liu, Tian-Tian Lv, Xiao-Mei Li, Xiang-Pei Li & Hai-Feng Pan. (2017) Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis. Clinical Rheumatology 36:10, pages 2193-2200.
Crossref
Crossref
Mikel Alberdi-Saugstrup, Marek Zak, Susan Nielsen, Troels Herlin, Ellen Nordal, Lillemor Berntson, Anders Fasth, Marite Rygg & Klaus Müller. (2017) High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis. Rheumatology International 37:5, pages 695-703.
Crossref
Crossref
Nausicaa Clemente, Cristoforo Comi, Davide Raineri, Giuseppe Cappellano, Domizia Vecchio, Elisabetta Orilieri, Casimiro L. Gigliotti, Elena Boggio, Chiara Dianzani, Melissa Sorosina, Filippo Martinelli-Boneschi, Marzia Caldano, Antonio Bertolotto, Luca Ambrogio, Daniele Sblattero, Tiziana Cena, Maurizio Leone, Umberto Dianzani & Annalisa Chiocchetti. (2017) Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Frontiers in Immunology 8.
Crossref
Crossref
Ágnes Szentpétery, Ágnes Horváth, Katalin Gulyás, Zsófia Pethö, Harjit Pal Bhattoa, Sándor Szántó, Gabriella Szücs, Oliver FitzGerald, Georg Schett & Zoltán Szekanecz. (2017) Effects of targeted therapies on the bone in arthritides. Autoimmunity Reviews 16:3, pages 313-320.
Crossref
Crossref
Yohei Hirano, Monowar Aziz, Weng-Lang Yang, Zhimin Wang, Mian Zhou, Mahendar Ochani, Adam Khader & Ping Wang. (2015) Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury. Critical Care 19:1.
Crossref
Crossref
Thierry Vincent, Maëlle Plawecki, Radjiv Goulabchand, Philippe Guilpain & Jean François Eliaou. (2015) Emerging clinical phenotypes associated with anti-cytokine autoantibodies. Autoimmunity Reviews 14:6, pages 528-535.
Crossref
Crossref
Tzeyu L. Michaud, Young Hee Rho, Tatyana Shamliyan, Karen M. Kuntz & Hyon K. Choi. (2014) The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials. The American Journal of Medicine 127:12, pages 1208-1232.
Crossref
Crossref
Kristyna Brabnikova-Maresova, Katerina Jarosova, Karel Pavelka & Jan J Stepan. (2014) Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. Arthritis Research & Therapy 16:5.
Crossref
Crossref
John A. Reynolds, Abigail C. Robertson, Ian N. Bruce & M. Yvonne Alexander. (2014) Improving cardiovascular outcomes in rheumatic diseases: Therapeutic potential of circulating endothelial progenitor cells. Pharmacology & Therapeutics 142:2, pages 231-243.
Crossref
Crossref
Pia Kivisäkk, Brian C Healy, Katiana Francois, Roopali Gandhi, Taha Gholipour, Svetlana Egorova, Velina Sevdalinova, Francisco Quintana, Tanuja Chitnis, Howard L Weiner & Samia J Khoury. (2013) Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Multiple Sclerosis Journal 20:4, pages 438-444.
Crossref
Crossref
Mie Jin LimSeong Ryul KwonKowoon JooMin Jung SonShin-Goo ParkWon Park. (2014) Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use. The Korean Journal of Internal Medicine 29:6, pages 807.
Crossref
Crossref
Haruyo Iwadate, Hiroko Kobayashi, Takashi Kanno, Tomoyuki Asano, Rie Saito, Shuzo Sato, Eiji Suzuki, Hiroshi Watanabe & Hiromasa Ohira. (2014) Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients. International Journal of Rheumatic Diseases 17:1, pages 50-56.
Crossref
Crossref
Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell & George A Wells. (2013) Etanercept for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews 2014:1.
Crossref
Crossref
P. Swärd, R. Frobell, M. Englund, H. Roos & A. Struglics. (2012) Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis) – a cross-sectional analysis. Osteoarthritis and Cartilage 20:11, pages 1302-1308.
Crossref
Crossref
A. Baroni, A. De Filippis, E. Buommino, R. A. Satriano & V. Cozza. (2011) Osteopontin, a protein with cytokine-like properties: a possible involvement in pemphigus vulgaris. Archives of Dermatological Research 304:3, pages 237-240.
Crossref
Crossref
Jürgen Glas, Julia Seiderer, Corinna Bayrle, Martin Wetzke, Christoph Fries, Cornelia Tillack, Torsten Olszak, Florian Beigel, Christian Steib, Matthias Friedrich, Julia Diegelmann, Darina Czamara & Stephan Brand. (2011) The Role of Osteopontin (OPN/SPP1) Haplotypes in the Susceptibility to Crohn's Disease. PLoS ONE 6:12, pages e29309.
Crossref
Crossref
S. Ermakov, A. Leonov, S. Trofimov, I. Malkin & G. Livshits. (2010) Quantitative genetic study of the circulating osteopontin in community-selected families. Osteoporosis International 22:8, pages 2261-2271.
Crossref
Crossref
Mingliang Chu, Peizeng Yang, Shengping Hou, Fuzhen Li, Yuanyuan Chen & Aize Kijlstra. (2011) Behçet's disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Human Immunology 72:6, pages 525-529.
Crossref
Crossref
Takuya UENO, Eishi MIYAZAKI, Masaru ANDO, Shin‐ichi NUREKI & Toshihide KUMAMOTO. (2010) Osteopontin levels are elevated in patients with eosinophilic pneumonia. Respirology 15:7, pages 1111-1121.
Crossref
Crossref
Daniel Ramirez, Parag Patel, Adrian Casillas, James Cotelingam, Peter Boggs & Sami L. Bahna. (2010) Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma. Annals of Allergy, Asthma & Immunology 104:6, pages 485-489.
Crossref
Crossref
KIORI SHIO, HIROKO KOBAYASHI, TOMOYUKI ASANO, RIE SAITO, HARUYO IWADATE, HIROSHI WATANABE, HIROFUMI SAKUMA, TETSUYA SEGAWA, MASAHIRO MAEDA & HIROMASA OHIRA. (2010) Thrombin-cleaved Osteopontin Is Increased in Urine of Patients with Rheumatoid Arthritis. The Journal of Rheumatology 37:4, pages 704-710.
Crossref
Crossref
DANKA GRCEVIC, ZRINKA JAJIC, NATAŠA KOVACIC, IVAN KREŠIMIR LUKIC, VEDRAN VELAGIC, FRANE GRUBIŠIC, SANJA IVCEVIC & ANA MARUŠIC. (2010) Peripheral Blood Expression Profiles of Bone Morphogenetic Proteins, Tumor Necrosis Factor-superfamily Molecules, and Transcription Factor Runx2 Could Be Used as Markers of the Form of Arthritis, Disease Activity, and Therapeutic Responsiveness. The Journal of Rheumatology 37:2, pages 246-256.
Crossref
Crossref
Susan Amanda Lund, Cecilia M. Giachelli & Marta Scatena. (2009) The role of osteopontin in inflammatory processes. Journal of Cell Communication and Signaling 3:3-4, pages 311-322.
Crossref
Crossref
F. Corallini, F. Bossi, A. Gonelli, C. Tripodo, G. Castellino, T. E. Mollnes, F. Tedesco, L. Rizzi, F. Trotta, G. Zauli & P. Secchiero. (2008) The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. Rheumatology 48:3, pages 293-298.
Crossref
Crossref